Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Gene Therapy

• Publication date

  2003-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301863PMID 12571648
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.

  2000cited by this paper
• Gene therapy of experimental brain tumors using neural progenitor cells

  2000cited by this paper
• Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study.

  2000cited by this paper
• Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine

  1999cited by this paper
• Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.

  1999cited by this paper
• Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors.

  1999cited by this paper
• Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells

  1999cited by this paper
• Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.

  1999cited by this paper
• Glucocorticoids inhibit IL-4 and mitogen-induced IL-4R alpha chain expression by different posttranscriptional mechanisms.

  1998cited by this paper
• Effects on brain tumor cell proliferation by an adenovirus vector that bears the interleukin-4 gene.

  1998cited by this paper
• Inhibition of Angiogenesis by Interleukin 4

  1998cited by this paper
• Novel biological functions of interleukin-4: formation of tube-like structures by vascular endothelial cells in vitro and angiogenesis in vivo.

  1998cited by this paper
• Colonization of neural allografts by host microglial cells: relationship to graft neovascularization.

  1997cited by this paper
• Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo.

  1997cited by this paper
• The paracrine role of tumour‐derived mIL‐4 on tumour‐associated endothelium

  1997cited by this paper
• Limited Efficacy of the HSV-TK/GCV System for Gene Therapy of Malignant Gliomas and Perspectives for the Combined Transduction of the Interleukin-4 Gene

  1997cited by this paper
• Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.

  1996cited by this paper
• Use of corticosteroids in neuro-oncology.

  1995cited by this paper
• Use of corticosteroids in neuro-oncology.

  1995cited by this paper
• Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-α and/or interferon-γ

  1993cited by this paper
• Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-alpha and/or interferon-gamma.

  1993cited by this paper

• Ion drugs for precise orthotopic tumor management by in situ the generation of toxic ion and drug pools

  2022cites this paper
• Immune checkpoint blockade in glioma

  2019cites this paper
• Controversial roles for dexamethasone in glioblastoma – Opportunities for novel vascular targeting therapies

  2019cites this paper
• Harnessing the immune system in glioblastoma

  2018cites this paper
• 11β-hydroxysteroid dehydrogenase type I inhibition in solid tumours

  2018cites this paper
• Convection-Enhanced Delivery in the Treatment of Glioblastoma.

  2018cites this paper
• A mitochondrial targeting fluorescent probe based on the covalently linked anti-inflammatory drug dexamethasone and Cy7

  2017cites this paper
• Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments

  2016cites this paper
• Response Pattern and Modeling of Tumor Treating Fields

  2016cites this paper
• New dimension of glucocorticoids in cancer treatment.

  2016cites this paper
• Response to: Comment on ‘Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'

  2015cites this paper
• MedChemComm Broadening the field of opportunity for medicinal chemists

  2015cites this paper
• RGD-peptides modifying dexamethasone: to enhance the anti-inflammatory efficacy and limit the risk of osteoporosis

  2015cites this paper
• Immunotherapy response assessment in neuro-oncology: a report of the RANO working group.

  2015cites this paper
• Comment on ‘Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'

  2015cites this paper
• Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis

  2014cites this paper
• Conjugation of dexamethasone to C60 for the design of an anti-inflammatory nanomedicine with reduced cellular apoptosis.

  2013cites this paper
• Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.

  2011cites this paper
• Influence de l'immunité et des facteurs angiogéniques sur la croissance des glioblastomes

  2010cites this paper
• Immunostimulants for malignant gliomas.

  2010cites this paper
• Role of glucocorticoids in breast cancer.

  2010cites this paper
• Glucocorticoid-mediated apoptosis resistance of solid tumors.

  2009cites this paper
• Reduced Glioma Growth Following Dexamethasone or Anti‐Angiopoietin 2 Treatment

  2008cites this paper
• Temozolomide in Newly Diagnosed Malignant Gliomas: Administered Concomitantly with Radiotherapy, and Thereafter as Consolidation Treatment

  2008cites this paper
• Methylprednisolone and Indomethacin Inhibit Oxidative Stress Mediated Apoptosis in Rat C6 Glioblastoma Cells

  2007cites this paper
• Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids

  2007cites this paper
• Interleukin-4/13 and Cancer

  2007cites this paper
• Current World Literature

  2007cites this paper
• Cell Cycle Arrest by Glucocorticoids May Protect Normal Tissue and Solid Tumors from Cancer Therapy

  2007cites this paper
• Glucocorticoid use in prostate cancer and other solid tumours: implications for effectiveness of cytotoxic treatment and metastases.

  2006cites this paper
• Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.

  2005influential citation
• Dexamethasone decreases temozolomide‐induced apoptosis in human gliobastoma T98G cells

  2005cites this paper
• Cancer Biology and Hormesis: Human Tumor Cell Lines Commonly Display Hormetic (Biphasic) Dose Responses

  2005cites this paper
• Glucocorticoid Receptor Counteracts Tumorigenic Activity of Akt in Skin through Interference with the Phosphatidylinositol 3-Kinase Signaling Pathway.

  2004cites this paper
• Interference of glucocorticoids with apoptosis signaling and host-tumor interactions

  2004cites this paper
• Advances in gene therapy and immunotherapy for brain tumors

  2003cites this paper
• Toward Cancer Therapy in Carcinomas Glucocorticoid Cotreatment Induces Apoptosis Resistance Updated Version Cited Articles Citing Articles E-mail Alerts Glucocorticoid Cotreatment Induces Apoptosis Resistance toward Cancer Therapy in Carcinomas 1

  year unknowncites this paper